New hope for advanced prostate cancer: drug may replace hormone therapy
Disease control
Recruiting now
This study tests whether adding the drug Pluvicto to standard radiation can lower the chance of prostate cancer coming back while avoiding the side effects of long-term hormone therapy. About 45 adults with advanced local prostate cancer will receive one or two doses of Pluvicto …
Phase: PHASE1, PHASE2 • Sponsor: Angela Y. Jia, MD PhD • Aim: Disease control
Last updated May 13, 2026 16:03 UTC